Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 379Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 5GALDERMA LABS LP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

IVERMECTIN

US Patent Number : 9233118

Drug Substance Claim :

Drug Product Claim :

Application Number : 206255

Patent Use Code : U-1631

Delist Requested :

Patent Use Description : TREATMENT OF INFLAMMAT...

Patent Expiration Date : 2034-03-13

blank

02

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

IVERMECTIN

US Patent Number : 9089587

Drug Substance Claim :

Drug Product Claim :

Application Number : 206255

Patent Use Code : U-1631

Delist Requested :

Patent Use Description : TREATMENT OF INFLAMMAT...

Patent Expiration Date : 2034-03-13

blank

03

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

IVERMECTIN

US Patent Number : 9233117

Drug Substance Claim :

Drug Product Claim :

Application Number : 206255

Patent Use Code : U-1631

Delist Requested :

Patent Use Description : TREATMENT OF INFLAMMAT...

Patent Expiration Date : 2034-03-13

blank

04

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

IVERMECTIN

US Patent Number : 9782425

Drug Substance Claim :

Drug Product Claim :

Application Number : 206255

Patent Use Code : U-1631

Delist Requested :

Patent Use Description : TREATMENT OF INFLAMMAT...

Patent Expiration Date : 2034-03-13

blank

05

arrow
Immuno-Oncology 360
Not Confirmed
arrow
Immuno-Oncology 360
Not Confirmed

IVERMECTIN

US Patent Number : 10206939

Drug Substance Claim :

Drug Product Claim :

Application Number : 206255

Patent Use Code : U-1631

Delist Requested :

Patent Use Description : TREATMENT OF INFLAMMAT...

Patent Expiration Date : 2034-03-13

blank